Article

Canada OKs marketing of STAAR Surgical TICL

Monrovia, CA—STAAR Surgical Co. has received approval from the Canadian Therapeutic Products Directorate to market its Visian Toric lens (TICL) in Canada.

Monrovia, CA-STAAR Surgical Co. has received approval from the Canadian Therapeutic Products Directorate to market its Visian Toric lens (TICL) in Canada. The posterior chamber phakic IOL corrects myopia and astigmatism without tissue removal, according to the company.

The Korean Food and Drug Administration, of South Korea, gave its approval to market the lens May 19.

Related Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr. Amir Ghanipour discusses light adjustable lenses for cataracts at EyeCon 2024
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
© 2024 MJH Life Sciences

All rights reserved.